Array BioPharma

Targeted small molecule therapeutics for treating cancer

Array (NASDAQ: ARRY) is a drug discovery and development company focusing on first-in-class small molecule therapeutics for cancer. The company has completed partnerships with a number of leading biopharmaceutical companies, including fellow Frazier portfolio company VentiRx. Array completed its IPO on NASDAQ in 2000.

Status

IPO in 2000 (NASDAQ: ARRY)

Year of Investment

1998

Strategy

Life Sciences

Subsector

Development-Stage Therapeutics

Location

Boulder, Colorado